InterventionsHuman trial
Effects on major adverse cardiovascular events in persons treated with sotagliflozin: Prespecified pooled analyses of the Phase 3 type 2 diabetes program
AHA Scientific Sessions 2025 Abstract
The paper
McGuire D, Hardin M, Davies M et al.
AHA Scientific Sessions 2025 Abstract · 3 Nov 2025
Presented at AHA Scientific Sessions 2025 · Abstract 4366301